DeLuxe Beauty & Wellness IVS — Credit Rating and Financial Key Figures
Credit rating
Company information
About DeLuxe Beauty & Wellness IVS
DeLuxe Beauty & Wellness IVS (CVR number: 39032198) is a company from GLOSTRUP. The company recorded a gross profit of -0.4 kDKK in 2020, demonstrating a decline of 0 % compared to the previous year. The operating profit was -0.4 kDKK, while net earnings were -0.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -0.1 %, which can be considered poor and Return on Equity (ROE) was -1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 32.7 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. DeLuxe Beauty & Wellness IVS's liquidity measured by quick ratio was 0.1 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2018 | 2019 | 2020 | |
---|---|---|---|
Volume | |||
Net sales | -90.58 | 185.80 | |
Gross profit | - 126.51 | 169.11 | -0.41 |
EBIT | - 126.51 | 169.11 | -0.41 |
Net earnings | -94.88 | 159.83 | -0.41 |
Shareholders equity total | -93.88 | 43.09 | 42.58 |
Balance sheet total (assets) | 65.03 | 694.02 | 130.25 |
Net debt | -23.50 | 160.83 | 57.52 |
Profitability | |||
EBIT-% | 91.0 % | ||
ROA | -79.6 % | 39.7 % | -0.1 % |
ROE | -145.9 % | 295.7 % | -1.0 % |
ROI | 89.5 % | -0.2 % | |
Economic value added (EVA) | -94.88 | 165.73 | 8.13 |
Solvency | |||
Equity ratio | -59.1 % | 6.2 % | 32.7 % |
Gearing | 776.9 % | 159.2 % | |
Relative net indebtedness % | -149.5 % | 256.7 % | |
Liquidity | |||
Quick ratio | 0.4 | 0.9 | 0.1 |
Current ratio | 0.4 | 1.1 | 1.5 |
Cash and cash equivalents | 23.50 | 173.93 | 10.26 |
Capital use efficiency | |||
Trade debtors turnover (days) | 786.0 | ||
Net working capital % | 103.6 % | 23.2 % | |
Credit risk | |||
Credit rating | BB | BB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.